Evidence map›Paper›PMID 34200001›Full record

ArticleVaccines2021

Knowledge, Attitudes, and Practices (KAP) toward the COVID-19 Vaccine in Oman: A Pre-Campaign Cross-Sectional Study.

Sabria Al-Marshoudi, Haleema Al-Balushi, Adil Al-Wahaibi, Sulien Al-Khalili, Amal Al-Maani, Noura Al-Farsi, Adhari Al-Jahwari, Zeyana Al-Habsi, Maryam Al-Shaibi, Mahfoodh Al-Msharfi and 5 more

Abstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Observational
  7. Article
  8. A comparative analysis of the effects of knowledge-attitude-practice nursing on mental state, sleep quality, and self-efficacy in cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sabria Al-MarshoudiDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
Haleema Al-BalushiDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
Adil Al-WahaibiDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.ORCID 0000-0002-5052-0800
Sulien Al-KhaliliDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
Amal Al-MaaniDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.ORCID 0000-0001-8322-8331
Noura Al-FarsiDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
Adhari Al-JahwariDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
Zeyana Al-HabsiDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
Maryam Al-ShaibiDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
Mahfoodh Al-MsharfiNational Center for Statistic and Information (NCSI), Muscat 133, Oman.
Ahlam Al-IsmailiNational Center for Statistic and Information (NCSI), Muscat 133, Oman.
Hood Al-BuloshiNational Center for Statistic and Information (NCSI), Muscat 133, Oman.
Bader Al-RawahiDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
Khalifa Al-BarwaniNational Center for Statistic and Information (NCSI), Muscat 133, Oman.
Seif Al-AbriDirectorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.ORCID 0000-0002-2669-6814

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oman is globally acknowledged for its well-structured immunization program with high vaccination coverage. The massive spread of misinformation brought on by the COVID-19 pandemic, as well as the easy access to various media channels, may affect acceptance of a vaccine, despite the inherent trust in the local system. This cross-sectional study evaluated the knowledge, attitudes, and practice (KAP) in Oman toward COVID-19 vaccines. It included 3000 randomly selected adults answering a structured questionnaire via telephone. Participants were 66.7% Omani, 76% male, and 83.7% without comorbidities. Their mean age was 38.27 years (SD ± 10.45). Knowledge of COVID-19's symptoms, mode of transmission, and attitudes toward the disease was adequate; 88.4% had heard of the vaccine, 59.3% would advise others to take it, 56.8% would take it themselves, and 47.5% would take a second dose. Males (CI = 2.37, OR = (2.00-2.81)) and Omani (CI = 1.956, OR = (4.595-2.397)) were more willing to be vaccinated. The history of chronic disease, source of vaccine knowledge, and education level were factors that affected the willingness to accept the vaccine. The Omani community's willingness to take the COVID-19 vaccine can be enhanced by utilizing social media and community influencers to spread awareness about the vaccine's safety and efficacy.

Indexed as

attitudeCOVID-19immunization programsknowledgeOmanpandemicspracticevaccines

Identifiers

PMID34200001
PMCPMC8228881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.